Since chronic inflammation can block GLP-1 receptors and disrupt gut hormone production, reducing it helps restore your bodys natural ability to produce and respond to GLP-1
The FDA approved the Wegovy pill (oral semaglutide) in December 2025 and Foundayo (orforglipron) in April 2026, giving patients two oral options for the first time
What the Research Shows on Semaglutide and Tirzepatide The relationship between GLP-1 medications and skin laxity is well-documented in the aesthetic-medicine literature, which increasingly frames GLP-1-associated skin changes as a legitimate concern requiring proactive management
Trusting your care provider is the best way to ensure that your plan remains safe and effective
It is found that EX can reverse the damage of renal tubular epithelial cells caused by a high-fat diet, and its effect is applied to simvastatin by reversing the down-regulation of SIRT1, preventing the production of reactive oxygen species and inhibiting the apoptosis of mitochondria (50)
Heres what you need to know about what really does, and doesnt, boost GLP-1